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Background and purpose: Audit is imperative in delivering consistent and safe radiotherapy and the UK
has a strong history of radiotherapy audit. The National Physical Laboratory (NPL) has undertaken audit
measurements since 1994 and this work examines results from these audits.
Materials and methods: This paper reviews audit results from 209 separate beams from 82 on-site visits
to National Health Service (NHS) radiotherapy departments conducted between June 1994 and February
2015. Measurements were undertaken following the relevant UK code of practice. The accuracy of the
implementation of absorbed dose calibration across the UK is quantified for MV photon, MeV electron
and kV X-ray radiotherapy beams.
Results: Over the measurement period the standard deviation of MV photon beam output has reduced
from 0.8% to 0.4%. The switch from air kerma- to absorbed dose-based electron code of practice con-
tributed to a reduction in the difference of electron beam output of 0.6% (p < 0.01). The mean difference
in NPL to local measurement for radiation output calibration was less than 0.25% for all beam modalities.
Conclusions: The introduction of the 2003 electron code of practice based on absorbed dose to water
decreased the difference between absolute dose measurements by the centre and NPL. The use of a single
photon code of practice over the period of measurements has contributed to a reduction in measurement
variation. Within the clinical setting, on-site audit visits have been shown to identify areas of improve-
ment for determining and implementing absolute dose calibrations.
 2017 Published by Elsevier Ireland Ltd on behalf of European Society of Radiotherapy & Oncology. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).1. Introduction
The National Physical Laboratory (NPL) develops and maintains
the primary standards for radiation dosimetry for the UK, including
those which are for external beam radiotherapy. The radiotherapy
treatment machines have dose traceable to the NPL primary stan-
dard graphite calorimeter which ensures accuracy and consistency.
Treatment machines are usually calibrated against a tertiary
dosimeter which has been calibrated against a secondary standardionisation chamber (the NPL designed NE 2561 ionisation
chambers1) which itself has been calibrated at the NPL through
comparison with the graphite calorimeter primary standard [1].
Once calibrated, the accuracy of delivered dose is assessed through
independent audit from another centre, the Radiotherapy Trials
Quality Assurance team (RTTQA), or from NPL. Reference dose audit
acts to verify that treatment machines have been calibrated correctly
using the relevant UK Code of Practice (CoP) for megavoltage photon
(MV) beams [2], electron (MeV) beams [3] or kilovoltage (kV) beams
[4,5], as used by all National Health Service (NHS) centres. There are
many methods used for dosimetric audit ranging from local auditNuclear
ufacture
Nuclear
nated as
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including TLDs, OSLDs, either involving a site visit or a postal audit
system [6–8].
The current UK CoP for MV beam dosimetry is the Institute of
Physical Sciences in Medicine (IPSM) 1990 Code of Practice [2].
This was the world’s first absorbed dose to water based protocol
and was developed in collaboration with the NPL, IPSM (now
known as the Institute of Physics and Engineering in Medicine
(IPEM)) and hospital physicists. This CoP provides a formalism
based on absorbed dose to water providing reduced uncertainty,
compared with the previous air kerma calibration method [3,9].
Audit of reference dosimetry for radiotherapy beams forms part
of a complete quality assurance system, with the first national
dosimetry intercomparison of MV photon beams completed in
1991 by Thwaites et al. [10], followed by an electron dosimetry
audit in 1996 by Nisbet and Thwaites [11]. In 1991 the IPSM
formed regional audit groups, dividing the UK into eight geograph-
ical regions. These groups would then conduct audits between the
associated centres on an annual basis, to escalate the number of
audits performed across the country, thus increasing confidence
in the UK radiotherapy service. In 1994, NPL was invited by IPEM
to provide independent audits to act as a link to the primary stan-
dard, initially performing one MV photon dosimetry audit per
region per year and later expanded to include electron and kV ref-
erence dosimetry audits, which are reported in this paper. Recently
more specific and complex audits such as the national rotational
radiotherapy audit [12], the national lung SABR audit [13], the
national stereotactic radiosurgery audit [14], and the national rec-
tal contact brachytherapy audit [15] have been included. This
definitive link between the regional audit groups and NPL has been
shown to reduce the uncertainty of the regional dose measure-
ments [16], thus it has proven to be a key aspect in the confidence
of accurate delivery of radiotherapy in the UK.
There are numerous recommendations specifying that refer-
ence dosimetry audit should take place between radiotherapy cen-
tres to ensure beam output calibrations are correctly applied, and
to maintain national consistency [17,18]. There is however no leg-
islation in the UK which requires that external audit is performed,
and hence are often conducted on an ad hoc basis [19].
This paper reviews the dosimetry audits for reference condi-
tions which the NPL has completed, from June 1994 to February
2015. This includes MV audits, which all follow the 1990 CoP [2],
MeV audits following both the 1996 CoP [20] and 2003 CoP [3]
and kV audits which follow the 1996 CoP [4] and its 2005 adden-
dum [5]. The analysis completed gives an overview of the state
of the accuracy of absolute dose calibrations in radiotherapy across
the UK throughout this time. The data included is for audits which
were completed within National Health Service (NHS) radiother-
apy departments and has been collated from a combination of
the audit reports sent to the host centres and the original data as
recorded during the audit.2. Methods and methods
2.1. General procedure
The NPL reference dosimetry audits have been conducted in the
same general manner for over 20 years whether for MV, MeV or kV
beams. NPL use their own calibrated chambers, electrometers,
phantoms, barometers and thermometers. A member of the NPL
dosimetry group visits the department and first takes measure-
ments of the beam quality index (tissue phantom ratio TPR20,10
for MV, R50,D for MeV, Half Value Layer (HVL) for kV) from which
calibration factors for the secondary standard ionisation chamber
are derived. An output measurement in reference conditions foreach beam quality under test was then made using both the NPL
equipment and the tertiary standard supplied by the host depart-
ment allowing a check of the calibration factor on the tertiary stan-
dard. These measurements are then compared to those given by
the host centre, which may be a result measured on the day as part
of a daily check, or calculated from a data table. As well as the
absorbed dose to water, the calibration of the local thermometer,
barometer and calculation of ion recombination are also checked,
providing a complete independent verification of the delivered
dose and all intermediate steps following the CoP, thus ensuring
each aspect of beam output measurement is verified. This contrasts
with postal audits which may use TLDs or Alanine in which only
the dose delivered can be compared. Within a given audit cycle,
the same NPL secondary standard chamber was used for all mea-
surements wherever possible.
In the clinical environment the chamber to be calibrated may be
positioned using a side-by-side phantom in the same beam as that
with a calibration. The measurements can then be compared using
the geometric mean to determine the calibration factor for the field
instrument. A method of direct replacement or substitution, where
only one chamber is positioned within the beam at a time, and
then the other is placed in the same location and further measure-
ments taken, to transfer the calibration, may also be used and was
the method employed for these audits.
2.2. Set up
2.2.1. Megavoltage photon (MV) set up
Dose measurements were made in a specially constructed
water-filled PMMA phantom that was the same as that used to cal-
ibrate the secondary standard chambers when sent from the hos-
pitals to NPL (in the time period considered for these audits).
This was a 30  30  30 cm open top box made from PMMA of wall
thickness of 1.0 cm (considered as 1.2 cm water equivalent). The
phantom contains inserts which allow the NE2561/NE2611 ionisa-
tion chamber to be positioned at water equivalent depths of 5.0,
7.0, 10.0 and 20.0 cm on the beam axis. The linac was then set to
produce a horizontal beam with the collimators set to give a
10.0  10.0 cm field at the radiation isocentre. The phantom was
positioned in a horizontal beam using the light field and cross hairs
on the linac. A plane flat mirror was used to align the phantom sur-
face perpendicular to the beam direction by reflecting the light
field back on to the head of the machine and ensuring the shadow
of the crosshair was coincident. The reference point of the chamber
was positioned on the central axis of the light field at the required
reference depth in water. The focal distance was set according to
local practice and the physical pointer, projected scale readings
and laser agreement were are compared.
2.2.2. Megavoltage electron (MeV) set up
Measurements were taken in NPL-owned WTe Solid Water
phantom material (St Bartholomew’s Hospital, London, UK) using
either a Roos or NACP-02 type ionisation chamber with matching
WTe chamber holder plate. A selection of WTe sheets were used,
ranging in thickness from 1 to 40 mm to enable the build-up depth
to be changed to match the requirements of the beam quality
under test. The WTe phantom was set up on the patient couch. A
vertical beam (gantry = 0) was used. The same arrangement was
used for beam quality, beam output and tertiary standard
calibration.
2.2.3. Kilovoltage photon (kV) set up
For the measurement of kV beam quality (HVL), an NPL-owned
jig was used that enabled a narrow beam geometry arrangement
for a horizontal beam. Radiographs of the NPL chamber used in this
geometry were taken to confirm correct alignment of the chamber.
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ing a range of (pre-measured) thicknesses were used to enable the
assessment of the HVL.
For beam output and tertiary standard calibration, an NPL-
owned jig was used to place either the NPL secondary standard
or the tertiary standard in air at the end of the required applicator
for a horizontal beam.
2.3. Beam quality
The beam quality is defined in different ways depending on the
type of beam; MV, MeV or kV. Full details of each are given in the
relevant Code of Practice.
2.3.1. Megavoltage photon (MV) beam quality
For MV beams the beam quality is the TPR20,10 [2]. This was
measured using a NE2561/NE2611 chamber and taken to be the
ratio of ionisation measurements at 20.0 cm and 10.0 cm deep in
water with a fixed focus to chamber distance of 100 cm and con-
stant field size (10.0  10.0 cm). Readings were corrected for tem-
perature, pressure and ion recombination. In practice any
differences in ion recombination with depth (dose per pulse) make
only a small change in TPR, which in turn gives only a small change
in absorbed dose calibration e.g. a change of 1.0% in the TPR leading
to a change of 0.16% in the calibration [4]. It should be noted that
this may not be the case in Flattening Filter Free (FFF) beams and
this issue is addressed in the recent IPEM publication [21], how-
ever no FFF beams were audited during the time period this work
covers.
2.3.2. Megavoltage electron (MeV) beam quality
For MeV beams there are two codes of practice discussed within
this work, referred to as the 1996 and 2003 CoPs [3,20]. Major dif-
ferences between them will be noted here, but a detailed discus-
sion is contained within the 2003 CoP. The 1996 CoP derives
absorbed dose to water from a 2 MV or Co-60 Air Kerma calibration
of the NE2561/NE2611 secondary standard chamber. E0 and Ez are
required to select physical data to convert to absorbed dose to
water and are determined from a measurement of R50,I/D. The
2003 MeV CoP greatly simplifies the required steps for the user
giving the absorbed dose to water calibration of the chamber trace-
able to the therapy electron primary standard calorimeter [22]. The
calibration factor for a secondary standard is given over a range of
beam qualities defined by the quality index R50,D which is the
depth at which the dose in water falls to 50% of its maximum along
the central axis. This is measured at 100 cm SSD in a field large
enough to ensure the result is independent of field size (the
required field size will generally increase with energy). Measure-
ments were taken in WTe Solid Water using either Roos or
NACP-02 chambers.
2.3.3. Kilovoltage photon (kV) beam quality
For kV beams the beam quality is specified using the concept of
the HVL which, in the case of the calibration of the secondary stan-
dard chamber at NPL, is defined in terms of the thickness of Alu-
minium or Copper required to reduce the air kerma rate by 50%.
This is then used to derive the calibration factor for the secondary
standard. Measurements were taken in air using NE2561/NE2611
chambers using narrow beam geometry with a setup to minimise
scatter conditions which was dependent upon the host centre’s
equipment location.
2.4. Radiation output
Radiation output is defined as the absorbed dose to water per
Monitor Unit (MU) (or on some units in terms of time usuallyseconds) measured for a given set of reference conditions. The
1990 MV photon code of practice did not explicitly state what con-
ditions should be used for reference dosimetry. The situation has
therefore arisen where different criteria are in use; for example
either 100 cm source to surface distance (SSD) or to isocentre is
used, with various measurement depths ranging from 5 to 10 cm.
Hence for MV photon dosimetry there exist a number of different
ways in which the reference conditions have been implemented.
Care must always be taken in ensuring the interpretation of the
reference conditions within a department is fully understood.
2.4.1. Megavoltage photon (MV) radiation output
Radiation output is measured at a reference depth in water of
5 cm, or 7 cm for beams with quality index greater than 0.75.
The output is measured at the beginning and end of each visit to
ensure consistency and detect any drift, the average of these is
taken for comparison with the locally provided value. The locally
provided value was generally measured on the same day and the
results may also have been derived from the centre’s tabulated
data. Dependent on the reference conditions on occasion a percent-
age depth dose correction from centre-measured data was
required.
2.4.2. Megavoltage electron (MeV) radiation output
1996 CoP: The output in terms of absorbed dose to water of the
electron beam is determined based on a chain of measurements
from an air kerma calibration of the NE2611 secondary standard.
The transfer of calibration is first by means of a cross calibration
of the secondary standard to a ‘‘Farmer” type chamber in a photon
beam, then transfer from the Farmer type chamber to plane paral-
lel electron chambers in a high energy electron beam (note whilst
the Farmer chamber may be used for calibration of higher energy
electron beams it is not recommended for use below an R50,D of
4 cm of water). The reference measurement depth (Zref) of 0.6
R50,D – 0.1 cm is calculated for calibration of beams, from the beam
quality index. Derivation of the calibration factor for other electron
energies may then be calculated as described in the CoP.
2003 CoP: The 2003 MeV CoP specifies absorbed dose to water
calibration factors given as a function of R50,D from the NPL calibra-
tion service [22]. It is recommended that parallel plate chambers
are used to measure the depth dose curves which will be used in
determining the calibration of the beam. Absorbed dose should
be determined in water at the calculated reference depth. Unless
a significant difference was found between the value given by
the host and that derived by NPL for R50,D, and hence Zref, the value
supplied by the host was used by NPL for the audit measurements.
2.4.3. Kilovoltage photon (kV) radiation output
The kV CoP (including its addendum in 2003) is split into three
sections; medium (0.5–4 mm Cu HVL), low (1.0–8 mm Al HVL), and
very low energy (0.035–1 mm Al HVL) X-rays. Methods for cali-
brating at the surface or at a depth of 2 cm in water are provided
for medium energy x-rays, and the method chosen will depend
upon the clinical need of a particular department. For calibration
based on dose at the surface an in-air method is used, whereas
dose at depth may be more accurately determined using measure-
ments in water. The addendum included revised values for Kch,
extension to the backscatter factors, mass energy absorption coef-
ficients, and a methodology to allow for the determination of
absorbed dose to water either at the surface or at 2 cm deep depen-
dent on clinical need. Measurements during audits were always
performed in air with the chamber positioned centrally at the
end of the applicator. The known thickness of the chamber is used
to correct the response of the chamber back to the end of the appli-
cator using the inverse square law. The CoPs are then used to con-
vert the air kerma measurements to dose at the surface of a
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of the centre.
2.5. Reporting of results and treatment of data
Results from each audit were reported as a ratio of the depart-
ment’s derived value to that of NPL. The beam quality, radiation
output and calibration factor of the field instrument are derived
during the audit and compared with the values in use within the
department. These measurements were all performed following
the recommendations of the relevant CoP in use within the depart-
ment. Audit regions were able to select which centre was audited.
Some had the same centre audited each time and they in turn
would audit the remaining regional centres. Others rotated the
NPL audit amongst the group. Due to this there are a number of
repeat visits to centres within this dataset, with the number of
repeat visits varying between regional groups.
Measurements have been categorised by beam type, electron
audits are then further divided according to which CoP was used.
For each beam type the mean difference in the dose between the
host centre and NPL was determined. Within this review the set
of audit measurement for an individual beam will be referred to
as a measurement set.
2.6. Statistical comparisons
The mean output ratio, standard deviation and standard devia-
tion of the mean of results have been compared. The output ratiosTable 1
Summary of NPL radiation output ratio measurements from audits carried out during the p
been included both separately and combined (as shown in italics).
Audits Radiation O
Beam Type No. Visits No. Beams Mean Differ
MV 47 81 +0.05%
MeV (1996) 6 14 +0.75%
MeV (2003) 17 84 +0.20%
MeV (All) 23 98 +0.27%
kV 12 30 +0.24%
All Beams 82 209 +0.18%
Fig. 1. Measured beam output ratios separated into the eight individual regional audit gr
().were compared using an independent t-test, assuming both equal
and unequal variances (often referred to as a Welch test).3. Results
A summary of the audits included in the analysis is given in
Table 1 with the standard deviation, minimum and maximum dif-
ferences given. There were no significant differences between the
modalities. A mean difference of <1% (<0.5% for absorbed dose to
water based COPs) between the Host and NPL for the measured
values of output was found. The standard deviation for all beams
was 0.74% (range 0.42–0.88% for each beam type).
A plot of all the measured output ratios is given in Fig. 1which
has been split by audit region and beam type. It is noted that there
were no MeV audits completed within audit region 4, and there
was a large range in the number of audits performed between
the different regions (range of 11 to 51). All MV results were within
±2%. All but three of the MeV results were within ±2%.
The variation in standard deviation for the previous 20 audits is
shown in Fig. 2 for MV and MeV results in order of completion. On
these plots the rolling standard deviation of the previous 20 results
shows that the variation in the MV results decreased over time.
After the first 20 audits the standard deviation of results was
approximately 0.8% which has fallen to less than 0.4 % through
the period of this analysis.
The results of measured output ratios for each beam type are
approximately normally distributed and centred about unity indi-
cating good agreement throughout the centres audited.eriod 1994 to February 2015. To allow comparison, data from the two MeV CoPs has
utput Measurements
ence Standard Deviation Min Max
0.68% 1.30% +1.99%
0.42% +0.10% +1.65%
0.75% 1.50% +2.70%
0.74% 1.50% +2.70%
0.88% 2.40% +2.10%
0.74% 2.40% +2.70%
oups. Mean value for each beam type in each group is indicated by a horizontal line
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from audits following the 1996 and 2003 MeV CoPs have been
compared. A statistically significant difference (p < 0.01) between
output ratios was found in the mean results obtained, with an
improvement of 0.64% seen with the 2003 CoP. There was no sig-
nificant difference in measurements seen between energies of
any modality.
A summary of the beam quality measurement is shown in
Table 2 demonstrating good consistency between centres. It should
be noted that for the kV results, the NPL measurements have a
standard uncertainty of ±2%, however this equates to a dose differ-
ence of less than 0.1%. For the MV results, the NPL measurements
have a standard uncertainty of ±0.2%, equating to a dose difference
of less than 0.1% in the calculated calibration factor. For the MeV
results, the NPL measurements have a standard uncertainty of
±0.2 cm. The variations in measurements of the beam quality give
rise to less than 0.5% variation in energy for all beam types. It is not
possible to give measurement specific uncertainty values for indi-
vidual measurements performed by the host centre. An indication
of the possible uncertainties in the centres beam calibration is
given in the CoPs which state the uncertainty in secondary stan-
dard dosemeter calibration is ±1.5% at the 95% confidence level
for MV and MeV beams and ±3% (1 standard deviation) for kV
beams.4. Discussion
A total of 82 audit visits were made during the specified time
period, with 209 individual beams being audited. There were only
five results outside the ±2% tolerance. Two of these were from kV
measurements, and three from MeV measurements. None were
from MV beams which are by far the most commonly used during
treatments. All of the MeV results which exceeded ±2% for the out-
put were from a single centre during a single visit. After further
investigation at the time of the audit it transpired that the host
centres output measurements were derived using the 1996 CoP,
whereas the audit was carried out using the 2003 CoP. Correcting
for this reduced all but one of the measurements to within the tol-
erance, with a single result remaining at +2.7%. Generally any
issues identified during the audit were investigated and resolved
during the visit.
The standard deviation of the measured MV output ratios
reduced from 0.8% to 0.4% over the period the audits were con-
ducted (Fig. 2). The initial standard deviation of 0.8% was already
excellent, and for this to reduce by half is testament to the success
of the process of dissemination that exists in the UK for dose from
the primary standard to the clinic. This is achieved through the
combination of the use of the CoP, dedicated secondary standard
instrumentation and UK regional audit network. NPL reference
dosimetry audits also make a valuable contribution in ensuring
the continued development and improvement in the traceability,
accuracy and precision of dose delivered to patients receiving
external beam radiotherapy.
This improvement in audit results can be compared to similar
audits, both within the UK and internationally. The audit com-
pleted by Thwaites et al. [10] included 64 UK centres, and mea-
sured 161 MV beams between 1987 and 1991 and found a
standard deviation of 1.4% and 1.5% for Co-60 and Linac beams
respectively, under reference conditions. It can be seen that the
recent NPL results have improved on those achieved in that study.
The MeV national audit conducted by Nisbet in 1996 [11] which
included 156 beams from 52 centres, gave a standard deviation
of 1.8%. The MeV results from the NPL audits also show less varia-
tion than this and have remained approximately constant at 0.7%.
Audits that use dosimeters such as TLDs rather than ionisationchambers have larger uncertainties, for example the IAEA postal
audits which are conducted worldwide show that the first time a
centre is audited, approximately 65% of results are within a ±5%
tolerance [23]. This improves with subsequent audits demonstrat-
ing one of the benefits of an audit program [24] not only for new,
but also for established centres.
The combined uncertainty for the secondary standard doseme-
ter calibration factor is ±1.5% at the 95% confidence level [2]. This
would equate to one standard deviation of 0.8% which closely
matches the 0.7% standard deviation measured for the MV beams.
An even closer match is seen for the 2003 MeV CoP which provides
an uncertainty of 1.5% at the 95% level, corresponding to a standard
deviation of 0.8%, which is that measured for the MeV results fol-
lowing the 2003 CoP.
It can be seen from the analysis of the 1996 and 2003 MeV CoP
data (Table 1) that changing from an air kerma to an absorbed dose
to water based CoP has reduced the difference in dose measure-
ments in electron beams between clinical radiotherapy centres
and NPL. A common misconception is that there is greatest uncer-
tainty for low energy electron beams. There was no significant dif-
ference observed between measured values, or their variation for
different beam energies within any beam type which could be
derived from this work. The change in MeV CoP from that based
on air kerma to absorbed dose has improved consistency when
implemented within a clinical environment, reducing the mean
variation of the measured NPL:Host outputs by 0.6% (p < 0.01).
In the UK the implementation of a new code is recommended to
be taken up by users within 3 years of implementation. During NPL
audit visits it has been found that in some cases this is not
achieved, indeed there have been occasions noted where the ‘‘new”
code has not been implemented for some time including two cases
where the 1990 MV code and the 2003 electron code were not
implemented for 10 years. On another occasion one department
implemented the 2003 electron code of practice in good time but
admitted they had never got round to implementing the 1996
code. It is sometimes cited that this is due to a desire to remain
consistent within the department, but this is then at the detriment
of consistency on a national perspective. Time pressure on staff and
availability of machine time is also given as a barrier to prompt
implementation. Whilst it is imperative that patient treatments
are the priority, there is on occasion a lack of understanding
between staff groups regarding the needs of all the professions in
ensuring the delivery of best practice in patient care.
These audits have been carried out by a small group of NPL staff
over a 20 year period as a result the procedures and practices dur-
ing these audits have remained consistent over that time. Further
to measuring the beam quality and absolute dose, which are
reported to the host centre through a written audit report, there
are additional benefits worth noting such as being able to check
the host’s temperature and atmospheric pressure readings against
NPL’s own calibrated instruments.
A more subtle benefit of ‘‘on site” audit is that there is time for
informal discussion of practices, in which potential problems may
be identified and these issues clarified or pre-empted. This is not
easy through postal forms of audit. While not formally provided
in the results, these discussions on general practice are a signifi-
cant contributory factor in ensuring the robustness of the complete
dosimetry chain from primary standard to patient dose delivery.
These discussions also provide a valuable opportunity to observe
and understand how the implementation and interpretation of rec-
ommendations have been conducted within individual depart-
ments. There is also great value in receiving feedback from the
end user community regarding the clarity (or lack of) in the CoP
or other recommendations regarding complexities and issues that
may not have been identified when a document was written. For
example the 1990 MV photon code of practice was undoubtedly
Fig. 2. Plot of MV (a) and MeV (b) output results in order of completion. The standard deviation of the previous 20 audits (after removing three known erroneous MeV results)
is shown by the dashed line. Bars indicate the standard uncertainty as given in the NPL report of the audit produced for the department.
Table 2
Summary of NPL beam quality measurements as measured during audit visits. MV are shown as percentage difference of TPR, MeV are shown as difference in the depth of R50,D
and kV are shown as percentage difference of HVL as a range of energies is included.
Beam Type Measure of Beam Quality No. Results Mean Min Max
MV TPR20,10 (NPL/Host) 81 0.11% 1.5% +1.2%
MeV R50,D (NPL  Host) 61 0.05 cm 0.28 cm +0.14 cm
kV HVL (NPL/Host) 26 0.04% 2.7% +7.7%
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further, it is often held up as an example of how simply a code can
be written. However this is a double edged sword, as recommenda-
tions of reference conditions were open to interpretation, and vari-
ations therefore exist in the adopted reference conditions
particularly regarding source to detector distance and field size
at the chamber.
The requirement for more clinically relevant quantities to
define dose has led to the development and improvement of pri-
mary standards away from air kerma based protocols to absorbed
dose to water. There is a continued requirement to drive further
improvement through the development of absorbed to dose to
medium protocols and through primary standards that closer
reflect the effect of radiation on the tissue at the cellular or even
DNA level [25]. For this work to have impact there must be a rigor-
ous, consistent and thorough method of dissemination from theprimary standard via dedicated CoPs and designated secondary
standard instrumentation. On occasion issues have arisen between
mismatched labels on equipment and calibration certificates; bet-
ter practice is to check the manufacturer’s unique serial number
stamped on to the instrument. As part of this dose traceability
chain, audit is a crucial part in ensuring the accurate and consistent
implementation of these systems.
This continued improvement in relevant quantity and the preci-
sion and accuracy of dose measurement feeds into clinical trials
helping to give a clearer picture of patient outcome. With the
increasing complexity of treatment techniques both from linacs
and indeed particle therapy there is a need to ensure ever more
consistency across departments and between techniques and
modalities in ensuring clear and beneficial results from patient
clinical trials. Consistency and comparability is also very relevant
with the increased interest in interrogating large data sets.
R.A.S. Thomas et al. / Physics and Imaging in Radiation Oncology 3 (2017) 21–27 27Continued development of UK primary standards for radiother-
apy, implementation of specific guidance through recommenda-
tions and codes of practice combined with an extensive regional
and national audit network provide a foundation for the imple-
mentation of safe and consistent radiotherapy dosimetry and ulti-
mately for patient benefit.
Acknowledgements
Audit is very much a collaborative process and the authors
would like to extend their thanks and gratitude to NPL staff who
have worked on the audit program and to our clinical colleagues
who have welcomed us into their departments. All have con-
tributed to the continued improvement of audit and hence radio-
therapy provision within the UK. We would like to acknowledge
funding from the National Measurement Systems.
References
[1] DuSautoy AR. The UK primary standard calorimeter for photon-beam absorbed
dose measurement. Phys Med Biol 1996;41:137–51. http://dx.doi.org/10.1088/
0031-9155/41/1/011.
[2] Lillicrap SC, Owen B, Williams JR, Williams PC. Code of Practice for high-energy
photon therapy dosimetry based on the NPL absorbed dose calibration service.
Phys Med Biol 1990;35(10):1355–60. http://dx.doi.org/10.1088/0031-9155/
35/10/301.
[3] Thwaites DI, DuSautoy AR, Jordan T, McEwen MR, Nisbet A, Nahum AE, et al.
The IPEM code of practice for electron dosimetry for radiotherapy beams of
initial energy from 4 to 25 MeV based on an absorbed dose to water
calibration. Phys Med Biol 2003;48:2929–70. http://dx.doi.org/10.1088/0031-
9155/48/18/301.
[4] Klevenhagen SC, Aukett RJ, Harrison RM, Moretti C, Nahum AE, Rosser KE. The
IPEMB code of practice for the determination of absorbed dose for x-rays
below 300 kV generating potential (0.035 mm Al-4 mm Cu HVL; 10–300 kV
generating potential). Phys Med Biol 1996;41:2605–25.
[5] Aukett RJ, Burns JE, Greener AG, Harrison RM, Moretti C, Nahum AE, et al.
Addendum to the IPEMB code of practice for the determination of absorbed
dose for x-rays below 300 kV generating potential (0.035 mm Al-4 mm Cu
HVL). Phys Med Biol 2005;50:2739–48. http://dx.doi.org/10.1088/0031-9155/
50/12/001.
[6] Hurkmans CW, Christiaens M, Collette S, Weber DC. Beam output audit results
within the EORTC Radiation Oncology Group network. Radiat Oncol
2016;11:160. http://dx.doi.org/10.1186/s13014-016-0733-4.
[7] Lye J, Dunn L, Kenny J, Lehmann J, Kron T, Oliver C, et al. Remote auditing of
radiotherapy facilities using optically stimulated luminescence dosimeters.
Med Phys 2014;41:32102. http://dx.doi.org/10.1118/1.4865786.
[8] Alvarez P, Kry SF, Stingo F, Followill D. TLD and OSLD dosimetry systems for
remote audits of radiotherapy external beam calibration. Radiat Meas
2017;100:1–4. http://dx.doi.org/10.1016/j.radmeas.2017.01.005.
[9] Andreo P, Burns DT, Hohlfeld K, Huq MS, Kanai T, Laitano F, et al. Technical
Reports Series No. 398. Absorbed Dose Determination in External BeamRadiotherapy: An International Code of Practice for Dosimetry Based on
Standards of Absorbed Dose to Water. International Atomic Energy Agency
(IAEA), Vienna; 2000. doi:10.1097/00004032-200111000-00017.
[10] Thwaites DI, Williams JR, Aird EG, Klevenhagen SC, Williams PC. A dosimetric
intercomparison of megavoltage photon beams in UK radiotherapy centres.
Phys Med Biol 1992;37:445–61.
[11] Nisbet A, Thwaites DI. A dosimetric intercomparison of electron beams in UK
radiotherapy centres. Phys Med Biol 1997;42:2393–409. doi: 10.1088/0031-
9155/42/12/007.
[12] Clark CH, Hussein M, Tsang Y, Thomas R, Wilkinson D, Bass G, et al. A multi-
institutional dosimetry audit of rotational intensity-modulated radiotherapy.
Radiother Oncol 2014 Nov;113(2):272–8. http://dx.doi.org/10.1016/j.
radonc.2014.11.015.
[13] Distefano G, Lee J, Jafari S, Gouldstone C, Baker C, Mayles H, et al. A national
dosimetry audit for stereotactic ablative radiotherapy in lung. Radiother Oncol
2017. http://dx.doi.org/10.1016/j.radonc.2016.12.016.
[14] Dimitriadis A. Assessing the dosimetric and geometric accuracy of stereotactic
radiosurgery [Ph.D. thesis]. University of Surrey; 2017.
[15] Humbert-vidan L, Sander T, Eaton DJ, Clark CH. National audit of a system for
rectal contact brachytherapy. Phys Imaging Radiat Oncol 2017;1:1–5. http://
dx.doi.org/10.1016/j.phro.2016.12.001.
[16] Palmer A, Mzenda B, Kearton J, Wills R. Analysis of regional radiotherapy
dosimetry audit data and recommendations for future audits. Br J Radiol
2011;84:733–42. http://dx.doi.org/10.1259/bjr/18691638.
[17] Mayles WPM, Lake R, Mckenzie A, Macaulay EM, Morgan HM, Jordan TJ, et al.,
editors. Physics Aspects of Quality Control in Radiotherapy. York: Institute of
Physics and Engineering in Medicine; 1999.
[18] The Royal College of Radiologists, Society and College of Radiographers,
Institute of Physics and Engineering in Medicine, National Patient Safety
Agency, British Institute of Radiology. Towards Safer Radiotherapy. Towards
Safer Radiotherapy. The Royal College of Radiologists; 2008.
[19] Clark CH, Aird EG, Bolton S, Miles EA, Nisbet A, Snaith JA, et al. Radiotherapy
dosimetry audit: three decades of improving standards and accuracy in UK
clinical practice and trials. Br J Radiol 2015;88:20150251. http://dx.doi.org/
10.1259/bjr.20150251.
[20] Burns DT, Klevenhagen SC, Nahum AE, Pitchford WG. The IPEMB code of
practice for electron dosimetry for radiotherapy beams of initial energy from 2
to 50 MeV based on an air kerma calibration. Institution of Physics and
Engineering in Medicine and Biology. Phys Med Biol 1996;41:2557–603.
http://dx.doi.org/10.1088/0031-9155/41/12/001.
[21] Budgell G, Brown K, Cashmore J, Duane S, Frame J, Hardy M, et al. IPEM topical
report 1: guidance on implementing flattening filter free (FFF) radiotherapy.
Phys Med Biol 2016;61:8360–94. http://dx.doi.org/10.1088/0031-9155/61/23/
8360.
[22] McEwen MR, Williams AJ, DuSautoy AR. Determination of absorbed dose
calibration factors for therapy level electron beam ionization chambers. Phys
Med Biol 2001;46:741–55. http://dx.doi.org/10.1088/0031-9155/46/3/310.
[23] Izewska J, Andreo P. The IAEA/WHO TLD postal programme for radiotherapy
hospitals. Radiother Oncol 2000;54:65–72. http://dx.doi.org/10.1016/S0167-
8140(99)00164-4.
[24] Izewska J, Wanklyn M, Grochowska P, Dunscombe P. PD-0384: The XX Postal
TLD Audit Programme: analysis of 10,660 results. Radiother Oncol 2015;115:
S184–5. http://dx.doi.org/10.1016/S0167-8140(15)40380-9.
[25] Galer S, Hao L, Gallop J, Palmans H, Kirkby K, Nisbet A. Design concept for a
novel SQUID-based microdosemeter. Radiat Prot Dosimetry 2011;143:427–31.
http://dx.doi.org/10.1093/rpd/ncq475.
